Lack of Association Between MIR155 Gene Variant rs767649 and Risk for Parkinson's Disease

Hortensia Alonso-Navarro1, Sofía Ladera-Navarro2, Pedro Ayuso2

  • 1Section of Neurology, Hospital Universitario del Sureste, 28500 Arganda del Rey, Spain.

Insights

This study investigated the association between a specific genetic variant (rs767649) in the MIR155 gene and Parkinson's disease (PD) risk. No significant link was found between this variant and PD in the studied Spanish population.

Area of Science:

  • Neuroscience
  • Genetics
  • Immunology

Background:

  • Neuroinflammation is implicated in Parkinson's disease (PD) pathogenesis.
  • MicroRNAs (miRNAs), such as miR-155, play a role in neuroinflammation.
  • A prior study suggested a link between the MIR155 gene variant rs767649 and PD risk.

Purpose of the Study:

  • To replicate the association between the MIR155 gene variant rs767649 and Parkinson's disease risk.
  • To analyze genotype and allele frequencies in a larger Spanish population.
  • To investigate the relationship between the variant and age at PD onset.

Main Methods:

  • Case-control study involving 459 PD patients and 460 healthy controls from Spain.
  • Genotyping of the MIR155 rs767649 single nucleotide variant (SNV) using TaqMan assay.
  • Analysis of genotype and allele frequencies under various inheritance models.

Main Results:

  • No statistically significant differences in genotype or allele frequencies of rs767649 were observed between PD patients and controls.
  • The age at PD onset did not differ across the MIR155 rs767649 genotypes.
  • The study did not find a significant association between MIR155 rs767649 variants and PD risk in this cohort.

Conclusions:

  • The MIR155 rs767649 variant is not significantly associated with Parkinson's disease risk in the studied Spanish population.
  • Limited statistical power due to low variant allele frequency means modest genetic effects cannot be ruled out.
  • Further research with larger cohorts may be needed to fully elucidate the role of MIR155 variants in PD.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.